The "Financial Times" reported on Sunday that the new proposal from pharmaceutical companies Pfizer and BioNTech to the European Union includes a clause for member states to pay half the price, equivalent to about ten euros (11 dollars), for each of the 70 million canceled COVID-19 vaccine doses. The report cited individuals familiar with the negotiations, stating that the revised contract would allow the European Union to upgrade to newer vaccines designed for any future COVID-19 variants.
Will the European Union Pay Half the Price for Canceled COVID Vaccines?
Share
